ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,121.77
1.14%
US Tech 100
17,416.80
2.00%
다우존스 지수
38,650.96
1.11%
Bitcoin
61,565.53
4.13%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Blueprint Medicines Corporation (BPMC)

  7. Blueprint Medicines Corporation (BPMC) 뉴스

BPMC Blueprint Medicines Corporation

107.14
0.14 (0.13%)
최종 업데이트: 01:38:36
15분 지연
기업명 주식 심볼 시장 주식 타입
Blueprint Medicines Corporation BPMC 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.14 0.13% 107.14 01:38:36
개장가 저가 고가 종가 전일 종가
109.82 106.32 110.93 107.00
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/05/202420:00PRNUSBlueprint Medicines Reports Strong First Quarter 2024..
18/04/202421:00PRNUSBlueprint Medicines to Report First Quarter 2024 Financial..
11/04/202421:00PRNUSBlueprint Medicines to Host Webcast and Conference Call..
05/04/202405:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
12/03/202407:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/03/202407:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/03/202407:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/03/202407:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/03/202407:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/03/202407:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/03/202407:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/03/202407:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/03/202407:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202406:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202406:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202406:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202406:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202406:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202406:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202406:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202406:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
07/03/202400:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/03/202408:19EDGAR2Form 144 - Report of proposed sale of securities
02/03/202405:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/02/202406:03EDGAR2Form 144 - Report of proposed sale of securities
23/02/202422:00PRNUSBlueprint Medicines Highlights AYVAKIT® (avapritinib)..
22/02/202422:20EDGAR2Form 8-K - Current report
17/02/202406:40EDGAR2Form S-8 - Securities to be offered to employees in employee..
16/02/202407:26EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/02/202421:05EDGAR2Form 8-K - Current report
15/02/202421:00PRNUSBlueprint Medicines Reports Fourth Quarter and Full Year..
15/02/202408:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/02/202406:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
01/02/202422:00PRNUSBlueprint Medicines to Report Fourth Quarter and Full Year..
30/01/202408:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/01/202406:13EDGAR2Form 144 - Report of proposed sale of securities
08/01/202422:03EDGAR2Form 8-K - Current report
08/01/202422:00PRNUSBlueprint Medicines Highlights 2024 Corporate Strategy and..
06/01/202406:01PRNUSBlueprint Medicines Announces Inducement Grants Under Nasdaq..
27/12/202306:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202306:09EDGAR2Form 144 - Report of proposed sale of securities
20/12/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202322:00PRNUSBlueprint Medicines to Present at 42nd Annual J.P. Morgan..
16/12/202306:23EDGAR2Form 144 - Report of proposed sale of securities
14/12/202305:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202322:05PRNUSBlueprint Medicines' AYVAKYT® (avapritinib) Receives..
12/12/202307:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202302:30PRNUSBlueprint Medicines' Leadership in Driving Continued..
08/12/202308:09EDGAR2Form 144 - Report of proposed sale of securities

최근 히스토리

NASDAQ
BPMC
Blueprint Medicines
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유